Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.

Ann Neurol. 2010 Aug;68(2):193-203. doi: 10.1002/ana.22043.

PMID:
20695012
2.

Vitamin D and multiple sclerosis.

Ascherio A, Munger KL, Simon KC.

Lancet Neurol. 2010 Jun;9(6):599-612. doi: 10.1016/S1474-4422(10)70086-7. Review.

PMID:
20494325
3.

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.

Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P.

Neurology. 2010 Jun 8;74(23):1852-9. doi: 10.1212/WNL.0b013e3181e1cec2. Epub 2010 Apr 28. Erratum in: Neurology. 2010 Aug 3;75(5):480. Neurology. 2010 Sep 14;75(11):1029. Dosage error in article text.

4.

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.

Becklund BR, Severson KS, Vang SV, DeLuca HF.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6418-23. doi: 10.1073/pnas.1001119107. Epub 2010 Mar 22.

5.

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.

Smolders J, Menheere P, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):243-6. doi: 10.1016/j.jsbmb.2010.03.001. Epub 2010 Mar 6.

PMID:
20211254
6.

Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism.

Doorenbos CR, van den Born J, Navis G, de Borst MH.

Nat Rev Nephrol. 2009 Dec;5(12):691-700. doi: 10.1038/nrneph.2009.185. Epub 2009 Oct 27. Review.

PMID:
19859070
7.

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.

Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R.

PLoS One. 2009 Aug 13;4(8):e6635. doi: 10.1371/journal.pone.0006635.

8.

Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis.

Haas J, Korporal M, Balint B, Fritzsching B, Schwarz A, Wildemann B.

J Neuroimmunol. 2009 Nov 30;216(1-2):113-7. doi: 10.1016/j.jneuroim.2009.06.011. Epub 2009 Jul 31.

PMID:
19646767
9.

Immunomodulatory effects of Vitamin D in multiple sclerosis.

Correale J, Ysrraelit MC, Gaitán MI.

Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.

10.

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC.

PLoS Genet. 2009 Feb;5(2):e1000369. doi: 10.1371/journal.pgen.1000369. Epub 2009 Feb 6.

11.

Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.

Korporal M, Haas J, Balint B, Fritzsching B, Schwarz A, Moeller S, Fritz B, Suri-Payer E, Wildemann B.

Arch Neurol. 2008 Nov;65(11):1434-9. doi: 10.1001/archneur.65.11.1434.

PMID:
19001161
12.

Multiple sclerosis.

Compston A, Coles A.

Lancet. 2008 Oct 25;372(9648):1502-17. doi: 10.1016/S0140-6736(08)61620-7.

PMID:
18970977
13.

Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis.

Michel L, Berthelot L, Pettré S, Wiertlewski S, Lefrère F, Braudeau C, Brouard S, Soulillou JP, Laplaud DA.

J Clin Invest. 2008 Oct;118(10):3411-9. doi: 10.1172/JCI35365.

14.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.

Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R.

Mult Scler. 2008 Nov;14(9):1220-4. doi: 10.1177/1352458508094399. Epub 2008 Jul 24.

PMID:
18653736
15.

Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.

Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud Z, El-Hajj Fuleihan G.

J Clin Endocrinol Metab. 2008 Jul;93(7):2693-701. doi: 10.1210/jc.2007-2530. Epub 2008 Apr 29.

16.

Epidemiology of multiple sclerosis: from risk factors to prevention.

Ascherio A, Munger K.

Semin Neurol. 2008 Feb;28(1):17-28. doi: 10.1055/s-2007-1019126. Review.

PMID:
18256984
17.

Vitamin D as an immune modulator in multiple sclerosis, a review.

Smolders J, Damoiseaux J, Menheere P, Hupperts R.

J Neuroimmunol. 2008 Feb;194(1-2):7-17. doi: 10.1016/j.jneuroim.2007.11.014. Epub 2008 Jan 4. Review.

PMID:
18177949
18.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

19.

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.

van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ.

J Neurol. 2007 May;254(5):581-90. Epub 2007 Apr 11.

PMID:
17426912
20.

Novel insights in the immune function of the vitamin D system: synergism with interferon-beta.

van Etten E, Gysemans C, Branisteanu DD, Verstuyf A, Bouillon R, Overbergh L, Mathieu C.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):546-51. Epub 2006 Dec 23.

PMID:
17254771
Items per page

Supplemental Content

Write to the Help Desk